Biblio

Export 1173 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is R  [Clear All Filters]
Journal Article
A. C. Robinson, Roncaroli, F., Chew-Graham, S., Davidson, Y. S., Minshull, J., Horan, M. A., Payton, A., Pendleton, N., and Mann, D. M. A., “The Contribution of Vascular Pathology Toward Cognitive Impairment in Older Individuals with Intermediate Braak Stage Tau Pathology.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1005-1015, 2020.
A. Pink, Przybelski, S. A., Krell-Roesch, J., Stokin, G. B., Roberts, R. O., Mielke, M. M., Knopman, D. S., Jack, C. R., Petersen, R. C., and Geda, Y. E., “Cortical Thickness and Depressive Symptoms in Cognitively Normal Individuals: The Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1273-1281, 2017.
R. L. Robinson, Rentz, D. M., Andrews, J. Scott, Zagar, A., Kim, Y., Bruemmer, V., Schwartz, R. L., Ye, W., and Fillit, H. M., “Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.”, J Alzheimers Dis, vol. 75, no. 2, pp. 437-450, 2020.
R. L. Robinson, Rentz, D. M., Andrews, J. Scott, Zagar, A., Kim, Y., Bruemmer, V., Schwartz, R. L., Ye, W., and Fillit, H. M., “Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.”, J Alzheimers Dis, vol. 75, no. 2, pp. 437-450, 2020.
R. R. Romano, Carter, M. A., Dietrich, M. S., Cowan, R. L., Bruehl, S. P., and Monroe, T. B., “Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1227-1233, 2021.
O. Turró-Garriga, Garre-Olmo, J., Calvó-Perxas, L., Reñé-Ramírez, R., Gascón-Bayarri, J., and Conde-Sala, J. Lluís, “Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up.”, J Alzheimers Dis, vol. 51, no. 2, pp. 357-66, 2016.
M. Golzari-Sorkheh, Weaver, D. F., and Reed, M. A., “COVID-19 as a Risk Factor for Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 1, pp. 1-23, 2023.
E. Pongan, Dorey, J. - M., Borg, C., Getenet, J. Claude, Bachelet, R., Lourioux, C., Laurent, B., Rey, R., and Rouch, I., “COVID-19: Association Between Increase of Behavioral and Psychological Symptoms of Dementia During Lockdown and Caregivers' Poor Mental Health.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1713-1721, 2021.
E. Pongan, Dorey, J. - M., Borg, C., Getenet, J. Claude, Bachelet, R., Lourioux, C., Laurent, B., Rey, R., and Rouch, I., “COVID-19: Association Between Increase of Behavioral and Psychological Symptoms of Dementia During Lockdown and Caregivers' Poor Mental Health.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1713-1721, 2021.
H. P Reddy, “A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 969-974, 2017.
L. Calderón-Garcidueñas, Mora-Tiscareño, A., Sánchez, G. Melo, Rodríguez-Díaz, J., Torres-Jardón, R., Styner, M., Mukherjee, P. S., Lin, W., and Jewells, V., “A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents.”, J Alzheimers Dis, 2015.
M. Buongiorno, Antonelli, F., Compta, Y., Fernandez, Y., Pavía, J., Lomeña, F., Ríos, J., Ramírez, I., García, J. Ramón, Soler, M., Cámara, A., Fernández, M., Basora, M., Salazar, F., Sanchez-Etayo, G., Valldeoriola, F., Barrio, J. Raúl, and Marti, M. Jose, “Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1261-1272, 2017.
M. Buongiorno, Antonelli, F., Compta, Y., Fernandez, Y., Pavía, J., Lomeña, F., Ríos, J., Ramírez, I., García, J. Ramón, Soler, M., Cámara, A., Fernández, M., Basora, M., Salazar, F., Sanchez-Etayo, G., Valldeoriola, F., Barrio, J. Raúl, and Marti, M. Jose, “Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1261-1272, 2017.
J. Subhash Rane, Bhaumik, P., and Panda, D., “Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro.”, J Alzheimers Dis, vol. 60, no. 3, pp. 999-1014, 2017.
A. - M. Miller, Balasa, M., Blennow, K., Gardiner, M., Rutkowska, A., Scheltens, P., Teunissen, C. E., Visser, P. Jelle, Winblad, B., Waldemar, G., and Lawlor, B., “Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe.”, J Alzheimers Dis, vol. 60, no. 1, pp. 201-210, 2017.
M. Pacheco-Herrero, Soto-Rojas, L. O., Reyes-Sabater, H., Garcés-Ramirez, L., López, Fde la Cruz, Villanueva-Fierro, I., and Luna-Muñoz, J., “Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease.”, J Alzheimers Dis, vol. 84, no. 3, pp. 917-935, 2021.
C. L. Fisher, Resnick, R. J., De, S., Acevedo, L. A., Lu, K. Ping, Schroeder, F. C., and Nicholson, L. K., “Cyclic cis-Locked Phospho-Dipeptides Reduce Entry of AβPP into Amyloidogenic Processing Pathway.”, J Alzheimers Dis, vol. 55, no. 1, pp. 391-410, 2017.
R. A. A. de Heus, Reumers, S. F. I., van der Have, A., Tumelaire, M., Tully, P. J., and Claassen, J. A. H. R., “Day-to-Day Home Blood Pressure Variability is Associated with Cerebral Small Vessel Disease Burden in a Memory Clinic Population.”, J Alzheimers Dis, vol. 74, no. 2, pp. 463-472, 2020.
D. W. Scharre, Weichart, E., Nielson, D., Zhang, J., Agrawal, P., Sederberg, P. B., Knopp, M. V., and Rezai, A. R., “Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 621-633, 2018.
J. - M. S. Leoutsakos, Yan, H., Anderson, W. S., Asaad, W. F., Baltuch, G., Burke, A., M Chakravarty, M., Drake, K. E., Foote, K. D., Fosdick, L., Giacobbe, P., Mari, Z., McAndrews, M. Pat, Munro, C. A., Oh, E. S., Okun, M. S., Pendergrass, J. Cara, Ponce, F. A., Rosenberg, P. B., Sabbagh, M. N., Salloway, S., Tang-Wai, D. F., Targum, S. D., Wolk, D., Lozano, A. M., Smith, G. S., and Lyketsos, C. G., “Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation.”, J Alzheimers Dis, vol. 64, no. 2, pp. 597-606, 2018.
H. Y. H. Hui, Ran, A. Ran, Dai, J. Jia, and Cheung, C. Y., “Deep Reinforcement Learning-Based Retinal Imaging in Alzheimer's Disease: Potential and Perspectives.”, J Alzheimers Dis, vol. 94, no. 1, pp. 39-50, 2023.
M. Tuwaig, Savard, M., Jutras, B., Poirier, J., D Collins, L., Rosa-Neto, P., Fontaine, D., and Breitner, J. C. S., “Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1589-1600, 2017.
D. G. Amen, Taylor, D. V., Meysami, S., and Raji, C. A., “Deficits in Regional Cerebral Blood Flow on Brain SPECT Predict Treatment Resistant Depression.”, J Alzheimers Dis, vol. 63, no. 2, pp. 529-538, 2018.
S. Sokolow, Li, X., Chen, L., Taylor, K. D., Rotter, J. I., Rissman, R. A., Aisen, P. S., and Apostolova, L. G., “Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 1, pp. 229-237, 2017.
S. Sokolow, Li, X., Chen, L., Taylor, K. D., Rotter, J. I., Rissman, R. A., Aisen, P. S., and Apostolova, L. G., “Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 1, pp. 229-237, 2017.

Pages